Business Standard

NTAGI meet this week to review vaccine data for 5-12 age group

A senior government official had told Business Standard last week that so far there was no scientific evidence to expand the vaccination programme to young children

vaccine
Premium

India has so far vaccinated 29.1 million children in the age group 12-14 years, and 101 million in the 15-17 age bracket.

Sohini Das Mumbai
India’s vaccine think-tank the National Technical Advisory Group on Immunisation (NTAGI) is likely to meet mid-week to review the data of Covid-19 vaccines Covovax and Corbevax for the age group 5-12 years, according to sources in the know.

This may pave the way for the inclusion of younger children in the national immunisation mission if the NTAGI finds the data satisfactory. A senior government official had told Business Standard last week that so far there was no scientific evidence to expand the vaccination programme to young children. “There are no plans yet to include children below 12 years in the vaccination

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in